Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.69), $0.12 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $13.91 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.